Locations
Vancouver, BC, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2009
Lungpacer Medical is a neurostimulation company dedicated to developing innovative interventional therapies that help critically ill patients wean off mechanical ventilation. Their key product, the Aero Pace System, received FDA Premarket Approval and is designed to stimulate the diaphragm muscle through nerve activation, enabling patients to breathe independently. This technology aims to reduce ventilator days, minimize trauma, and improve patient outcomes, positioning Lungpacer as a leader in the respiratory care market. With over 125 patents and a strong clinical research background, Lungpacer is poised for significant impact in critical care settings.
Something looks off?On-site & Remote